Weifang Yaxing Chemical Co., Ltd.

SSE:600319.SS

5.63 (CNY) • At close May 7, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997
Revenue 910.416824.85846.653192.70249.2941,655.122,010.1641,949.7811,457.4381,311.5031,489.0241,628.2441,713.3992,111.6312,097.8441,721.6262,081.4041,944.6951,635.5411,211.781990.085674.065606.289597.642502.617444.387354.958327.722
Cost of Revenue 892.05806.056714.935192.33744.4971,436.5271,790.3021,729.9741,396.0631,299.0471,467.011,557.1261,619.2011,889.5422,041.3781,681.2941,920.2771,728.0651,432.7661,068.473864.479551.39501.455485.497373.904334.574265.636247.278
Gross Profit 18.36618.794131.7180.3654.796218.594219.861219.80661.37512.45622.01471.11894.198222.08956.46640.332161.126216.63202.775143.308125.606122.675104.834112.145128.713109.81489.32280.444
Gross Profit Ratio 0.020.0230.1560.0020.0970.1320.1090.1130.0420.0090.0150.0440.0550.1050.0270.0230.0770.1110.1240.1180.1270.1820.1730.1880.2560.2470.2520.245
Reseach & Development Expenses 10.19511.2838.5995.152.2574.6192.6924.24911.86239.3247.8771.140.9361.36900000000000000
General & Administrative Expenses 12.12314.5514.889-16.17371.49152.49326.09216.86119.54830.21332.75830.37533.29222.99966.77845.17749.63760.9362.49951.89245.02236.61134.10230.48123.32226.31418.59434.306
Selling & Marketing Expenses 4.22611.1449.9696.5772.92257.86364.12168.0254.59846.06740.89246.24832.97941.55744.36837.92534.83533.35229.27219.89222.09917.08815.91910.9518.1919.9385.7525.284
SG&A 16.34918.40224.858-9.59674.413110.35690.21284.88174.14676.2873.65176.62466.27164.556111.14683.10284.47294.28391.77171.78467.12153.69850.02141.43231.51336.25224.34639.59
Other Expenses 99.609-22.78435.90253.098-32.59544.743-1.405-7.11399.93113.4182.212210.68735.86918.292120.9942.25246.5345.467-1.5150.782-1.332-0.336-0.1439.7090.906-0.9130.2330.343
Operating Expenses 126.1538.51669.35948.65244.074159.718146.81135.327129.462173.735118.566130.882122.243124.852124.04290.13884.74394.28391.77171.78467.12153.69850.02141.43231.51336.25224.34639.59
Operating Income -107.7876.62280.989259.979-39.278112.6194.51233.727-86.816-380.823-198.615-211.879-311.611-80.06-84.401-127.726-13.18833.89356.5642.63344.02168.19855.71260.31579.29269.31341.88529.246
Operating Income Ratio -0.1180.0080.0961.349-0.7970.0680.0020.017-0.06-0.29-0.133-0.13-0.182-0.038-0.04-0.074-0.0060.0170.0350.0350.0440.1010.0920.1010.1580.1560.1180.089
Total Other Income Expenses Net 9.460.060.291253.9060.09-83.402-1.405-7.11398.6542.7011.747181.594-443.395-125.939112.791-72.41845.034-82.986-57.477-28.612-22.242-0.768-0.652.06-2.413-1.1150.205-0.007
Income Before Tax -98.3276.682119.109193.049-25.67529.2173.10726.6158.886-378.121-196.868-22.751-471.44-61.76828.389-125.47431.84639.36155.54543.16342.64767.4355.06169.35679.90368.19842.0929.238
Income Before Tax Ratio -0.1080.0080.1411.002-0.5210.0180.0020.0140.006-0.288-0.132-0.014-0.275-0.0290.014-0.0730.0150.020.0340.0360.0430.10.0910.1160.1590.1530.1190.089
Income Tax Expense 0.4230.40610.2650.023-8.25483.402-15.2820.71153.87-56.348-15.431-0.68422.552-7.4379.202-31.441-2.1285.0878.1975.8792.95814.7337.4398.2659.6058.4335.5645.333
Net Income -97.0356.364108.844193.026-17.42-54.1853.10726.61526.782-331.753-179.1788.793-477.169-55.4477.21-110.60615.68420.11532.28637.28439.68952.69747.62261.09170.29859.76536.52623.905
Net Income Ratio -0.1070.0080.1291.002-0.353-0.0330.0020.0140.018-0.253-0.120.005-0.278-0.0260.003-0.0640.0080.010.020.0310.040.0780.0790.1020.140.1340.1030.073
EPS -0.250.020.310.61-0.055-0.170.010.080.08-1.05-0.570.01-1.51-0.180.02-0.350.050.0640.10.0890.0840.130.110.130.210.190.110.075
EPS Diluted -0.250.020.310.61-0.055-0.170.010.080.08-1.05-0.570.01-1.51-0.180.02-0.350.050.0640.10.0890.0840.130.110.130.210.190.110.075
EBITDA 50.618127.193220.369234.608-28.384146.567140.443164.899211.826-151.17122.143230.561-182.459203.437305.169100.435234.18230.165209.775151.461119.408128.894111.655113.832127.558101.36464.97640.854
EBITDA Ratio 0.0560.1540.261.217-0.5760.0890.070.0850.145-0.1150.0150.142-0.1060.0960.1450.0580.1130.1180.1280.1250.1210.1910.1840.190.2540.2280.1830.125